[Emergency Pod] Peptides - Part 2 with Dr. Jonathan Slotkin of Scrub Capital
[Emergency Pod] Peptides - Part 2 with Dr. Jonathan Slotkin of Scrub Capital  
Podcast: Lifers with Christina Farr
Published On: Sat Apr 18 2026
Description: In this special episode of Lifers, Christina Farr sits down with Dr. Jonathan Slotkin (neurosurgeon, CMO, and co-founder of Scrub Capital) for a timely conversation on peptides and what the latest HHS announcements mean for patients and the longevity industry. Jon breaks down his own protocol, makes the case that the longevity conversation has too often left women out, and closes with a watch-out for investors: the potential descheduling of testosterone. —SPONSOR: Granola Granola AI, The AI notepad for people in back-to-back meetings: https://granola.ai/lifers with code: LIFERS Interested in sponsoring the show? lifers@a16zstudios.com —LINKS: Scrub Capital: https://scrubcapital.com/ Ashley Winter on Twitter: https://x.com/AshleyGWinter Peptide Reclassification: https://peptide-db.com/guides/fda-peptide-reclassification-2026 Testosterone/TRT expansion: https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men  Chrissy Farr on YouTube: https://www.youtube.com/@LiferswithChristinaFarr Chrissy Farr on Instagram: https://www.instagram.com/cfarr/ Subscribe to the Second Opinion Newsletter: https://secondopinion.media/ Chrissy’s Book: The Storyteller's Advantage: https://www.chrissyfarr.com/books  —FOLLOW:Jon:https://www.linkedin.com/in/slotkinjr https://x.com/slotkinjr  Christina Farr:https://www.linkedin.com/in/christinafarr/ https://x.com/chrissyfarr  —TIMESTAMPS:(00:00) Intro(01:08) What are peptides(02:25) Safety and FDA nuance(04:53) Clinician survey tribes(07:15) Jon’s personal protocol(10:03) Women and hormone gaps(14:08) Sponsor: Granola(14:47) Why peptides are everywhere(17:11) Finding the right provider(20:47) Follow John and final nugget(21:49) Testosterone descheduling watch(22:31) Wrap